In our clinical study, we examined metabolic and inflammatory parameters, kidney function, and leptin levels among patients afflicted with hypertension, obesity, type 2 diabetes, and cardiovascular diseases. This evidence concerns the gene LEP and type 2 diabetes mellitus.